PDT Partners’s Clovis Oncology, Inc. CLVS Stock Holding History

PDT Partners’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-11,261	Closed	-$65K	–	960
2021 Q2	$65K	Sell	11,261 -41,135	-79%	-$241K	﹤0.01%	772
2021 Q1	$368K	Buy	+52,396	New	+$351K	0.03%	565
2019 Q1	–	Sell	-201,218	Closed	-$3.61M	–	520
2018 Q4	$3.61M	Buy	+201,218	New	+$4.11M	0.2%	146
2017 Q3	–	Sell	-19,361	Closed	-$1.81M	–	585
2017 Q2	$1.81M	Sell	19,361 -51,686	-73%	-$3.16M	0.07%	270
2017 Q1	$4.52M	Buy	+71,047	New	+$4.32M	0.24%	151
2015 Q4	–	Sell	-33,997	Closed	-$3.13M	–	1046
2015 Q3	$3.13M	Buy	+33,997	New	+$2.94M	0.07%	320
2013 Q4	–	Sell	-32,596	Closed	-$1.98M	–	1251
2013 Q3	$1.98M	Buy	32,596 +28,178	+638%	+$2M	0.05%	498
2013 Q2	$296K	Buy	+4,418	New	+$199K	0.01%	1257

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PDT Partners's CLVS Position: Q3 2021 in Review

PDT Partners sold out of Clovis Oncology, Inc. (CLVS) in Q3 2021, closing a stake of 11,261 shares — an estimated $65K sold.

PDT Partners first reported a position in CLVS in Q2 2013 and held it in 8 quarters. The position peaked at $4.52M in Q1 2017. 157 funds tracked by Wall St. Rank hold CLVS as of Q3 2021.

PDT Partners reported no remaining Clovis Oncology, Inc. position as of Q3 2021 after selling out during the quarter.
PDT Partners sold 11,261 Clovis Oncology, Inc. shares in Q3 2021, an estimated $65K.
PDT Partners first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 8 quarters.
PDT Partners's Clovis Oncology, Inc. position peaked at $4.52M in Q1 2017.
157 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2021.

Based on PDT Partners's 13F filing for Q3 2021, filed 15 Nov 2021.